Ernst-Günter Afting

Directeur/Membre du Conseil chez BioMedCredit AG

Profil

Ernst-Günter Afting currently works at Olympus Europa GmbH, as Director, BioMedCredit AG, as Member-Supervisory Board from 2012, and Olympus Europa Holding GmbH, as Member-Supervisory Board.
Dr. Afting also formerly worked at Hoechst AG, as Chairman & CEO-Pharmaceutical Division in 1993, Roussel Uclaf SA, as President & Chief Executive Officer from 1993 to 1995, GSF-National Research Center for Environment & Health GmbH, as President & Chief Executive Officer from 1995 to 2006, Intercell AG, as Vice Chairman-Supervisory Board from 2012 to 2013, Avontec GmbH, as Chairman-Supervisory Board in 2010, Biovertis AG, as Chairman-Supervisory Board, Quidel Corp., as Director, Titan Pharmaceuticals, Inc., as Director, Sequenom, Inc., as Independent Director from 2012 to 2014, Quikbyte Software, Inc., as Director, Behringwerke AG, as Director in 1989, Enanta Pharmaceuticals, Inc., as Independent Class III Director from 2012 to 2017, Sorrento Therapeutics, Inc., as Independent Director from 2013 to 2014, and Retrotope, Inc., as Director.
Dr. Afting received his graduate degree and doctorate degree from the University of Freiburg and undergraduate degree from the University of Münster.

Postes actifs de Ernst-Günter Afting

Sociétés	Poste	Début
BioMedCredit AG	Directeur/Membre du Conseil	18/05/2011
Olympus Europa Holding GmbH	Directeur/Membre du Conseil	-
Olympus Europa GmbH	Directeur/Membre du Conseil	-

Anciens postes connus de Ernst-Günter Afting

Sociétés	Poste	Fin
ENANTA PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	16/02/2017
SEQUENOM, INC.	Directeur/Membre du Conseil	10/06/2014
SORRENTO THERAPEUTICS, INC.	Directeur/Membre du Conseil	30/01/2014
Intercell AG	Directeur/Membre du Conseil	28/05/2013
Avontec GmbH	Président	16/06/2010